2024, Circulation and Lipid disorders

Abstract 4112869: Development of a Sitosterolemia Risk Prediction Scale (SRPS): A Screening Tool

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4112869-A4112869, November 12, 2024. Introduction:Sitosterolemia, a hereditary disorder marked by elevated plant sterol levels, presents diagnostic challenges due to its similarity to other lipid disorders.

Genetic predisposition

Genetic predisposition Lipid disorders Innovation Risk Factors

Abstract 4145926: The Importance of Dietary Salt in the Process of Atherosclerosis The Results of the International Survey

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4145926-A4145926, November 12, 2024. It was launched in March 2024 and promoted through multiple online channels. Introduction:Excessive dietary salt intake is a recognized ASCVD risk factor, and causes approximately 1.89 million deaths annually. to even 53%.

Atherosclerosis

Atherosclerosis Diet Lipid disorders Risk Factors

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

MARCH 8, 2024

Getty Images milla1cf Fri, 03/08/2024 - 14:35 March 8, 2024 — Novo Nordisk today announced that the U.S. director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research , in a statement issued by the FDA. Last accessed February 2024. 10,11 In the U.S.,

Obesity

Obesity Heart Disease Heart attacks Heart Attack

Cardiovascular Update

Abstract 4112869: Development of a Sitosterolemia Risk Prediction Scale (SRPS): A Screening Tool

Abstract 4145926: The Importance of Dietary Salt in the Process of Atherosclerosis The Results of the International Survey

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

Stay Connected